Efficacy and safety of canagliflozin compared with placebo in older patients with type 2 diabetes mellitus: a pooled analysis of clinical studies

BACKGROUND: Canagliflozin is a sodium glucose co-transporter 2 inhibitor developed for the treatment of patients with type 2 diabetes mellitus (T2DM). The efficacy and safety of canagliflozin were evaluated in patients with T2DM <65 and ≥65 years of age. METHODS: Pooled data from 4 randomised, pl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sinclair, Alan, Bode, Bruce, Harris, Stewart, Vijapurkar, Ujjwala, Mayer, Cristiana, Fung, Albert, Shaw, Wayne, Usiskin, Keith, Desai, Mehul, Meininger, Gary
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4021426/
https://ncbi.nlm.nih.gov/pubmed/24742013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6823-14-37
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados